Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder

Cancer Research

Volumn 62, Issue 3, 2002, Pages 809-818

  Hartmann, Arndt ^a   Schlake, Gudrun ^a   Hofstaedter, Ferdinand ^a   Knuechel, Ruth ^a   Zaak, Dirk ^b   Hungerhuber, Edwin ^b   Hofstetter, Alfons ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER DISEASE; CARCINOMA IN SITU; CHROMOSOME 17P; CHROMOSOME 9; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME MICRODISSECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENE PROBE; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTERPHASE; MALE; MICROSATELLITE MARKER; PRIORITY JOURNAL; UROTHELIUM;

AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA IN SITU; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 9; EXONS; FEMALE; GENE DELETION; GENES, P53; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PRECANCEROUS CONDITIONS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0036468296     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. A randomized trial of intravesical doxorubicin and immunotherapy with Bacille Calmette-Guerin for transitional-cell carcinoma of the bladder
2. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence
3. Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: Preliminary results
4. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid-results of 1012 fluorescence endoscopies
5. Histological typing of urinary bladder tumours
6. Neoplasm of the urinary bladder
7. Flat intraepithelial lesions of the urinary bladder
8. Natural history of urothelial dysplasia of the bladder
9. Carcinoma in situ of the urinary bladder. Clues to host involvement in human carcinogenesis
10. Two molecular pathways to transitional cell carcinoma of the bladder
11. Urothelial dysplasia and carcinoma in situ of the bladder
12. Cytogenetic studies of carcinoma in situ of the bladder: Prognostic implications
13. Genetic modeling of human urinary bladder carcinogenesis
14. Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder
15. Multiple mutation analyses in single tumor cells with improved whole genome amplification
16. Oligoclonality of early lesions of the urothelium as determined by microdissection-supported genetic analysis
17. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma
18. Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer
19. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis
20. Identification of expressed genes by laser-mediated manipulation of single cells
21. Laser microdissection of breast cancer reveals a high degree of tumor heterogeneity in microsatellite analysis
22. Immortalisation of human urothelial cells
23. Whole genome amplification from a single cell: Implications for genetic analysis
24. An Alu polymorphism intragenic to the TP53 gene
25. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
26. p53 gene mutations inside and outside of exons 5-8: The patterns differ in breast and other cancers
27. The identification of monoclonality in human aberrant crypt foci
28. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma
29. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma
30. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis
31. Evidence of independent origin of multiple tumors from patients with prostate cancer
32. Partial allelotype of carcinoma in situ of the human bladder
33. Chromosome 9 deletions and recurrence of superficial bladder cancer: Identification of four regions of prognostic interest
34. Molecular genetics in carcinoma of the bladder
35. Four tumor suppressor loci on chromosome 9q in bladder cancer: Evidence for two novel candidate regions at 9q22.3 and 9q31
36. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid
37. Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells
38. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation
39. Field cancerization, clonality, and epithelial stem cells: The spread of mutated clones in epithelial sheets
40. Clonal origin bladder cancer
41. Distinct pattern of p53 mutations in bladder cancer: Relationship to tobacco usage
42. Influence of cigarette smoke and schistosomiasis on p53 gene mutation in urothelial cancer